ACP

Acuta Capital Partners Portfolio holdings

AUM $147M
1-Year Est. Return 491.59%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+491.59%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$371M
AUM Growth
+$126M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
77
New
Increased
Reduced
Closed

Top Buys

1
+$51.2M
2
+$15M
3
+$9.52M
4
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$4.24M
5
NVTA
Invitae Corporation
NVTA
+$4.06M

Top Sells

1
+$12.2M
2
+$7.78M
3
+$5.12M
4
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
+$4.57M
5
ANAB icon
AnaptysBio
ANAB
+$3.96M

Sector Composition

1 Healthcare 70.42%
2 Communication Services 0%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$2.1M 0.57%
+15,000
27
$1.92M 0.52%
+100,000
28
$1.45M 0.39%
+58,525
29
$1.41M 0.38%
+564,200
30
$1.31M 0.35%
64,955
31
$1.04M 0.28%
71,500
-302,007
32
$839K 0.23%
+111,912
33
$40K 0.01%
182
34
$12K ﹤0.01%
96,833
35
$5K ﹤0.01%
96,833
36
– –
-90,000
37
– –
-165,690
38
– –
0
39
– –
-22,100
40
– –
0
41
– –
0
42
– –
0
43
– –
0
44
– –
0
45
– –
0
46
– –
0
47
– –
0
48
– –
0
49
– –
0
50
– –
0
1
2
3 4